Nucleic Acid Standards for Biosecurity Act (HR3029)
Current understanding
HR3029 would direct NIST to conduct measurement research and develop stakeholder-based consensus best practices and technical standards for nucleic acid synthesis screening, operational security controls, and AI-related risks in engineering biology and biomanufacturing. The bill codifies and expands NIST activities originally directed by the 2023 AI executive order, adds congressional reporting requirements, and explicitly folds AI risk into the biosecurity standards mandate. Status: introduced.
Evidence log
- 2026-01-29 — Biosecurity Modernization and Innovation Act of 2026: cross-connection with biosecurity-modernization-innovation-act-2026: Both address domestic biosecurity policy modernization — S3741 as a general modernization framework, HR3029 as a specific NIST standards-setting mandate for nucleic acid synthesis screening. (novelty: 3)
- 2026-04-21 — Engineering Biology Readiness Act: cross-connection with engineering-biology-readiness-act: Both address engineering biology risk and readiness — S4363 through a Homeland Security-referred readiness bill, HR3029 through NIST measurement and standards for nucleic acid synthesis screening. (novelty: 3)
- 2026-06-11 — Web of Biological Data Act of 2026: cross-connection with web-of-biological-data-act-2026: S4770’s biological-data framework complements HR3029’s nucleic acid measurement and screening standards as parallel tracks in a biosecurity/bio-data governance stack. (novelty: 3)
- 2026-03-12 — AI-Ready Bio-Data Standards Act: cross-connection with ai-ready-bio-data-standards-act: Both bills use federal standards-setting (data interoperability vs. synthesis screening/biosecurity) to govern the AI-biology interface. (novelty: 3)